rs748311158
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001164507.2(NEB):c.17416G>A(p.Glu5806Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,608,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.17416G>A | p.Glu5806Lys | missense_variant | Exon 109 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
| NEB | ENST00000427231.7 | c.17416G>A | p.Glu5806Lys | missense_variant | Exon 109 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | 
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152212Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000832  AC: 2AN: 240332 AF XY:  0.00000769   show subpopulations 
GnomAD4 exome  AF:  0.00000275  AC: 4AN: 1456330Hom.:  0  Cov.: 32 AF XY:  0.00000276  AC XY: 2AN XY: 723786 show subpopulations 
GnomAD4 genome  0.00000657  AC: 1AN: 152212Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74364 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
ClinVar
Submissions by phenotype
Nemaline myopathy 2    Uncertain:1 
This sequence change replaces glutamic acid with lysine at codon 5806 of the NEB protein (p.Glu5806Lys). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and lysine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with NEB-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at